Dr. Benedetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Childrens Way
Nashville, TN 37232Phone+1 615-936-0899Fax+1 615-936-1767
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2015 - 2018
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018
- University of Washington School of MedicineFellowship, Clinical Ethics, 2014 - 2015
- University of WashingtonResidency, Pediatrics, 2011 - 2014
- University of Washington School of MedicineClass of 2011
Certifications & Licensure
- TN State Medical License 2018 - 2025
- AL State Medical License 2020 - 2020
- MA State Medical License 2015 - 2020
- WA State Medical License 2011 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 2 citationsLong-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study.Andrew J Murphy, Jack Brzezinski, Lindsay A Renfro, Brett Tornwall, Marcus M Malek
International Journal of Cancer. 2024-11-15 - 9 citationsPopulation-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment.Ioannis A. Ziogas, Fei Ye, Zhiguo Zhao, Lea Matsuoka, Martin I. Montenovo
Journal of the American College of Surgeons. 2020-06-01 - 1 citationsA case of pancreatoblastoma in a child with Simpson-Golabi-Behmel syndrome: Highlighting the importance of alpha fetoprotein monitoring.Hira A Hasan, Lindsey S Johnstone, Daniel J Benedetti
Pediatric Blood & Cancer. 2024-08-01
Press Mentions
- Minimally Invasive Treatment for Wilms Tumor Brings BenefitsJuly 20th, 2022
- Multi-Institutional Study of Wilms Tumor Facilitates Enrollment, Optimizes TreatmentFebruary 28th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: